Right atrial and ventricular function in risk stratification of patients with pulmonary artery hypertension

31 August 2024 (15:57 - 16:09)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Miss Jiajun Guo

Sichuan (China)

4 More presentations in this session

Presentation thumbnail

Severe aortic stenosis is associated with left atrial prothrombotic flow changes that persists despite successful aortic valve replacement

Doctor M. Spartera (Oxford, GB)

Abstract Slides Video

Presentation thumbnail

Impact of epicardial adipose tissue and atrial functional impairment in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

Doctor J. Gronwald (Goettingen, DE)

Abstract Slides Video

Presentation thumbnail

LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome

Doctor M. Lima (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Fenofibrate modulates cardiac energy metabolism in moderate-severe aortic stenosis: a mechanistic double-blinded randomised controlled MR trial

Doctor S. Monga (Oxford, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Exploring valvular and congenital heart disease with cardiac magnetic resonance

The Event

Event poster

ESC Congress 2024

31 August 2024 15:57 CET

You may be interested in

Congress Presentation

A single echocardiographic or hemodynamic parameter improves risk stratification in prevalent patients with pulmonary arterial hypertension

Congress Session

Phenotyping and risk stratification in pulmonary arterial hypertension

Congress Presentation

The added value of echocardiography in PAH risk assessment an AI machine learning-derived analysis of the ULTRA RIGHT VALUE registry

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources